Rhaponticum carthamoides
What's the taxonomical classification of Rhaponticum carthamoides?
Rhaponticum carthamoides belongs to the kingdom Plantae and is classified within the phylum Streptophyta. Following its taxonomic hierarchy, it is placed in the class Equisetopsida and the subclass Magnoliidae. As a member of the order Asterales, it falls under the family Asteraceae. Finally, the plant is identified by its specific genus, Rhaponticum, and its species designation, carthamoides.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Rhaponticum |
| Species | carthamoides |
What are the morphological characteristics of this plant?
Rhaponticum carthamoides has a perennial, woody-based herbaceous structure characterized by large, deeply pinnatifid leaves and robust, terminal inflorescences of yellow flower heads. The basal leaves are long and heavily lobed, often displaying a somewhat hairy or pubescent texture on their undersides. As the plant matures, it produces tall, erect flowering stalks that bear numerous capitula arranged in dense, corymb-like clusters. These flower heads consist of many small, golden-yellow tubular florets typical of the Asteraceae family. The overall growth habit is sturdy and can reach significant heights in its natural alpine or subalpine habitats.
What is the geographical distribution of this plant?
This plant is native to the mountainous regions of Central and Southern Europe, specifically spanning from the Alps and the Carpathians to the Balkan Peninsula. Its distribution is primarily restricted to high-altitude habitats where rocky limestone substrates are prevalent. Populations are frequently found in subalpine zones and on steep, scree-covered slopes. The species also appears in specific pockets of the Mediterranean mountains. These localized environments provide the unique microclimates necessary for its survival.
How is this plant cultivated?
This plant Rhaponticum carthamoides is cultivated in temperate climates using well-drained, loamy soils that maintain consistent moisture without becoming waterlogged.
Growers typically plant the perennial herb during the spring or autumn to allow root systems to establish before extreme temperature shifts. Regular weeding and organic fertilization are necessary to support the development of its medicinal roots and leaves. Because it thrives in semi-shaded areas, it is often integrated into diverse agroecological systems rather than intensive monocultures.
Proper cultivation ensures the high concentration of bioactive compounds required for pharmaceutical applications.
What parts of this plant are used medicinally?
This plant Rhaponticum cartthamoides is utilized medicinally through the use of its rhizome, root, shoot, and above-ground parts. The underground rhizome and root systems are often harvested to extract potent bioactive compounds. Additionally, the green shoot and other above-ground parts contain essential phytochemicals used in various preparations. These different components are processed to create extracts known for their antioxidant and anti-inflammatory properties. Using the entire plant structure allows for a comprehensive approach to its therapeutic applications.
According to a study published by "Molecules (Basel, Switzerland)", Rhaponticum carthamoides is an endemic and medicinal plant at risk of extinction because of the massive harvesting of its roots and rhizomes. The study evaluated the effect of light-emitting diodes on phenolic compounds in shoots of the plant cultured in vitro. The liquid medium and blue light enhanced the sum of all identified caffeoylquinic acid derivatives to 6 mg/g DW, which was about three-fold higher than the white light and control. HPLC-UV analysis confirmed that chlorogenic acid was the primary compound in shoot extracts at levels of 1.19-3.25 mg/g DW. Other components found in the shoots included 3,5-di-O-caffeoylquinic acid, 4,5-di-O-caffeoylquinic acid, and a tricaffeoylquinic acid derivative 2.
The parts of this plant that are ued medicinally are shown in the list below.
- rhizome
- root
- shoot
- above-ground part
What traditional systems uses this plant?
This plant, known as Rhaponticum carthamoides or sea buckthorn relative, has been used in traditional Eastern European folk medicine primarily for treating digestive disorders and liver ailments.
Historically, practitioners in regions like Bulgaria and Russia utilized various parts of the plant to alleviate symptoms of gastritis and stomach ulcers. The roots and leaves were often prepared as decoctions or infusions to support gallbladder function and promote overall hepatic health. Additionally, some historical records suggest the plant was employed to manage inflammatory conditions and support the immune system.
These traditional practices laid the groundwork for modern research into its bioactive compounds.
What are the pharmacological activities of Rhaponticum carthamoides?
This plant has adaptogen, anti-inflammatory, anticancer, antioxidant, and immunomodulatory pharmacological activities. Its unique chemical composition allows it to help the body resist various forms of physical and emotional stress. The presence of specific bioactive compounds provides significant protection against oxidative damage in cells. These substances also work to regulate the immune system and reduce harmful inflammatory responses throughout the body. Furthermore, research suggests that its constituents may play a role in inhibiting the progression of certain cancer cells.
According to a study published by "Nutrients", Rhaponticum carthamoides is considered to be a naturally occurring adaptogen. This plant extract has the ability to enhance the body's stability against physical loads without increasing oxygen consumption. About 50 years ago, plant adaptogens were first used in professional sports due to their high potential to increase the body's resistance to stress and to improve physical endurance. Data from meta-analysis showed that plant adaptogens could provide a number of benefits in the treatment of chronic fatigue, cognitive impairment, and immune protection.
The primary pharmacological activities of this plant are shown in the list below.
- adaptogen
- anti-inflammatory
- anticancer activity
- antioxidant
- immunomodulatory
What medicinal compounds this plant contains?
This plant contains chlorogenic acid, beta-ecdysone, flavonoids, polyacetylenes, and sesquiterpene lactones as its primary medicinal compounds. The presence of chlorogenic acid contributes significantly to the plant's antioxidant and metabolic properties. Beta-ecdysone acts as a potent ecdysteroid that may assist in muscle strengthening and physical performance. Various flavonoids within the plant provide additional anti-inflammatory and protective cellular effects. Furthermore, the polyacetylenes and sesquiterpene lactones offer unique bioactive characteristics that support its overall therapeutic potential.
According to a study published by "International journal of molecular sciences", Rhaponticum carthamoides is a rare, pharmacopoeial, and medicinal plant. The study investigated the effects of sucrose concentrations from 0 to 7% on the plant's transformed root biomass and metabolite production. While 7% sucrose achieved the highest dry weight of roots at 31.17 g L-1, a 3% sucrose concentration provided optimal yields of 511.1 mg L-1 for caffeoylquinic acid derivatives (CQAs) and 38.9 mg L-1 for flavonoids. The most abundant specialized metabolites identified among the CQAs were chlorogenic acid, 3,5- and 4,5-di-O-caffeoylquinic acids, 1,4,5-O-tricaffeoylquinic acid, and a tentatively-identified tricaffeoylquinic acid derivative 1. These findings suggest that Rhaponticum carthamoides transformed roots serve as an efficient source of CQAs with health-promoting activities.
The primary medicinal compounds of this plant are shown in the list below.
- chlorogenic acid
- ecdysteroids
- flavonoids
- polyacetylenes
- sesquiterpene lactones
What health conditions is this plant used for?
This plant is used for treating cancer and inhibiting carcinogenesis, specifically targeting human glioma and various nervous system tumors. Its bioactive compounds act on cellular pathways to prevent the uncontrolled growth of malignant cells. Research indicates that the plant helps mitigate oxidative stress, which is a key factor in the development of many diseases. By neutralizing free radicals, it provides a protective mechanism against the cellular damage that leads to tumor progression. These properties make it a significant subject of study in the fight against neuro-oncological conditions.
According to a study published by "Phytochemistry", Rhaponticum carthamoides has been used for centuries in eastern parts of Russia for its marked medicinal properties. This review based on 117 literary sources discusses how the species possesses a broad spectrum of pharmacological effects on several organs such as the brain, blood, cardiovascular and nervous systems. It also affects biochemical processes and physiological functions including proteosynthesis, work capacity, reproduction, and sexual function. Extracts and preparations from the plant exhibit antioxidant, immunomodulatory, anticancerogenic, antimicrobial, antiparasitic and insect antifeedant or repellent activities. The data analysis of its characteristics supports the view that this species has beneficial therapeutic properties and potential as an effective adaptogenic herbal remedy.
The main health conditions this plant is used for are shown in the list below.
- cancer
- carcinogenesis
- human glioma
- nervous system tumors
- oxidative stress
What are the herbal preparations of this plant?
This plant is used to create diverse medicinal herbal preparations including Rhaponticum carthamoides extracts, crude ethanolic extract, essential oil, and phytoadaptogenic preparations. These various forms allow for different methods of administration and therapeutic applications in treating physiological stress. The crude ethanolic extract provides a concentrated source of active compounds for systemic use. Essential oil derived from the plant offers a highly potent aromatic and topical option. Finally, the specialized phytoadaptogenic preparations help the body maintain homeostasis during periods of physical or mental strain.
According to a study published by "The Journal of pharmacy and pharmacology", Rhaponticum carthamoides transformed root (TR) and root of soil-grown plant (NR) extracts exhibit cytotoxic effects and apoptotic activity in human glioma primary cells. These Rhaponticum carthamoides root extracts inhibit cell growth and induce apoptosis in a dose-dependent manner. The extracts work by up-regulating the pro-apoptotic Bax protein and down-regulating the anti-apoptotic Bcl-2 protein, which increases the ratios of Bax/Bcl-2 protein levels. Additionally, treatment with NR and TR extracts results in an increase of the p53 protein level and a reduction of mitochondrial membrane potential (ΔΨm) in glioma cells. These findings regarding Rhaponticum carthamoides root extracts provide insight into potential anticancer activity.
The main herbal preparations of this plant are shown in the list below.
- Rhaponticum carthamoides extracts
- Crude ethanolic extract
- Essential oil
- Phytoadaptogenic preparations
What side effects this plant can have?
This plant can induce apoptosis in cancer cells and inhibit the proliferation of human glioma cells. These bioactive properties suggest that the plant contains specific phytochemicals capable of disrupting the survival mechanisms of malignant brain tumors. By triggering programmed cell death, the extracts actively reduce the growth rate of aggressive cancer cell lines. Scientific research indicates that these effects are primarily driven by the plant's ability to interfere with cellular division processes. Consequently, Rhaponticum carthamoides is being investigated for its potential therapeutic role in oncology.
According to a study published by "The Journal of pharmacy and pharmacology", Rhaponticum carthamoides transformed root (TR) and soil-grown plant (NR) extracts inhibit cell growth and induce apoptosis in a dose-dependent manner in human glioma cells. The root extracts were found to up-regulate the pro-apoptotic Bax protein and down-regulate the anti-apoptotic Bcl-2 protein, which increases the ratios of Bax/Bcl-2 protein levels. Treatment with NR and TR extracts also resulted in an increase of the p53 protein level and a reduction of the mitochondrial membrane potential (ΔΨm) in glioma cells. These findings regarding the cytotoxic effect and apoptotic activity of Rhaponticum carthamoides extracts may offer a new insight into its potential anticancer activity.
The main side effects this plant can have are shown in the list below.
- apoptosis induction
- inhibition of human glioma cell proliferation
What herbs are paired with Rhaponticum carthamoides?
This plant pairs most effectively with bitter herbs such as gentian root, dandelion root, and artemisia to enhance its digestive and bittertonic properties.
Combining Rhaponticum carthamoides with adaptogens like ashwagandha or holy basil can help balance its physiological effects on the nervous system. For those seeking to support liver function, blending it with milk thistle or burdock root creates a potent synergistic effect for detoxification. These combinations are often formulated in tinctures or teas to maximize the absorption of its unique bioactive compounds.
Selecting specific pairings depends largely on whether the intended goal is metabolic support or stress management.